Electrochemical Determination of the Anticancer Drug Amsacrine at a ds-DNAModified Graphene Carbon Paste Electrode and its Application as a Label-FreeElectrochemical Biosensor

Publish Year: 1395
نوع سند: مقاله کنفرانسی
زبان: English
View: 304

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

ELECTROCHEMISTRY012_003

تاریخ نمایه سازی: 5 آذر 1397

Abstract:

DNA has a key role in the process of life as heritage data are carried with it. DNA is an important target for smaller molecules such as medicines, metals, and carcinogens [1].The interaction between several anticancer medicines with DNA has been investigated using different methods. Although, these methods are time-consuming and expensive and need more materials, Recently, the electrochemical investigation of interaction between anticancer drugs and DNA has been increased. Among these methods, DNA electrochemical biosensors are one of the main groups [2]. Amsacrine is a well-known anticancer agent with a good activity against refractory acute leukemias as well as Hodgkin’s and non-Hodgkin’s lymphomas [3]. In current research, based on the interaction between dsDNA and amsacrine, amsacrine was determinedby a simple, fast, reliable, and sensitive DNA biosensor. After optimizing the main experimental parameters, This DNA-coated GPE was fabricated to evaluate its performance analytically. A linear dynamic range of 7.0×10-7– 10×10-4 M was obtained for amsacrine.Ultimately, the proposed biosensor was found to be capable of successfully analyzing human serum and urine samples.

Authors

Hadi Mahmoudi Moghaddam

Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences,Kerman, Iran

Hadi Beitollahi

Environment Department, Institute of Science and High Technology and Environmental Sciences, GraduateUniversity of Advanced Technology, Kerman, Iran

Gholamreza Dehghannoudeh

Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences,Kerman, Iran

Hamid forootanfar

Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences,Kerman, Iran